Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042

Conditions:   Metastatic Cancer;   Advanced Cancer;   Solid Tumor
Interventions:   Drug: Niraparib;   Drug: TSR-042;   Drug: Carboplatin-Paclitaxel
Sponsor:   Tesaro, Inc.
Not yet recruiting

http://ift.tt/2kJGzPE